Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study

OncoTargets and Therapy ◽

10.2147/ott.s63168 ◽

2014 ◽

pp. 1051 ◽

Author(s):

Govind K Babu ◽

Ashok K Vaid ◽

Bhawna Sirohi ◽

Ravi B Diwakar ◽

Raghunadha Rao ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Open Label Phase

Download Full-text

Patupilone for the treatment of recurrent/progressive brain metastases in patients (pts) with non-small cell lung cancer (NSCLC): An open-label phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.2033 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 2033-2033 ◽

Author(s):

L. E. Abrey ◽

P. Wen ◽

R. Govindan ◽

H. Reimers ◽

J. R. Rigas ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Open Label Phase

Download Full-text

6549 POSTER Treatment of recurrent or progressive brain metastases with patupilone in patients with non-small cell lung cancer (NSCLC): results of a multicenter, open-label phase II study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71377-0 ◽

2007 ◽

Vol 5 (4) ◽

pp. 372

Author(s):

L. Abrey ◽

A. Johri ◽

P.Y. Wen ◽

R. Govindan ◽

H.J. Reimers ◽

...

Keyword(s):

Lung Cancer ◽

Brain Metastases ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Open Label Phase

Download Full-text

Randomized, open-label phase II study of motesanib or bevacizumab in combination with paclitaxel and carboplatin (P/C) for advanced nonsquamous non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7528 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7528-7528 ◽

Author(s):

G. R. Blumenschein ◽

F. F. Kabbinavar ◽

H. Menon ◽

T. Mok ◽

J. Stephenson ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Open Label Phase

Download Full-text

An open-label phase II study of the Hsp90 inhibitor ganetespib (STA-9090) as monotherapy in patients with advanced non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.7500 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 7500-7500 ◽

Author(s):

K. Wong ◽

M. Koczywas ◽

J. W. Goldman ◽

E. H. Paschold ◽

L. Horn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Hsp90 Inhibitor ◽

Small Cell Lung ◽

Open Label Phase

Download Full-text

An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC)

Lung Cancer ◽

10.1016/j.lungcan.2016.12.019 ◽

2017 ◽

Vol 104 ◽

pp. 126-130 ◽

Author(s):

Mark M. Awad ◽

Quincy S-C Chu ◽

Leena Gandhi ◽

Joe J. Stephenson ◽

Ramaswamy Govindan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Open Label Phase ◽

Download Full-text

Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study

Lung Cancer ◽

10.1016/j.lungcan.2012.01.012 ◽

2012 ◽

Vol 77 (1) ◽

pp. 121-127 ◽

Author(s):

In-Jae Oh ◽

Hee-Jung Ban ◽

Kyu-Sik Kim ◽

Young-Chul Kim

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Open Label Phase

Download Full-text

Open-label multicenter randomized phase II study of docetaxel plus bevacizumab or pemetrexed plus bevacizumab for elderly (≥75 years old) patients (pts) with previously untreated advanced non-squamous non-small cell lung cancer (NSCLC): TORG1323

Annals of Oncology ◽

10.1093/annonc/mdy292.025 ◽

2018 ◽

Vol 29 ◽

pp. viii506

Author(s):

T. Honda ◽

T. Kouzuki ◽

Y. Tsunezuka ◽

N. Seki ◽

T. Shibayama ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Old Patients ◽

Randomized Phase Ii

Download Full-text

A randomised, multicentre open-label phase II study to evaluate the efficacy, tolerability and pharmacokinetics of oral vinorelbine plus cisplatin versus intravenous vinorelbine plus cisplatin in Chinese patients with chemotherapy-naive unresectable or metastatic non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2019.08.22 ◽

2019 ◽

Vol 11 (8) ◽

pp. 3347-3359 ◽

Author(s):

Yunpeng Yang ◽

Jianhua Chang ◽

Cheng Huang ◽

Yiping Zhang ◽

Jie Wang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Chinese Patients ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Open Label Phase

Download Full-text

P-489 An open label, multicenter, non-comparative phase II study of weekly intravenous vinorelbine (V) and topotecan (T) in chemotherapy-naive patients (pts) with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)80982-1 ◽

2005 ◽

Vol 49 ◽

pp. S245

Author(s):

S. Grunberg ◽

J. Clarkson ◽

H. Harper ◽

H. Gomolin ◽

T. Guthrie ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Download Full-text

ASCEND-3: A single-arm, open-label, multicenter phase II study of ceritinib in ALKi-naïve adult patients (pts) with ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.8060 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 8060-8060 ◽

Author(s):

Enriqueta Felip ◽

Sergey Orlov ◽

Keunchil Park ◽

Chong-Jen Yu ◽

Chun-Ming Tsai ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Adult Patients ◽

Small Cell Lung ◽

Multicenter Phase

Download Full-text